mLab

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

Retrieved on: 
Tuesday, June 1, 2021
Hygiene, Articles, Cloud infrastructure, mLab, NoSQL, Organic growth, Sterilization, mLab, Disinfectant, Organic food, Computing, Organic

LAKEWOOD, Colo., June 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (4Q21) and full year ended March 31, 2021 (FY21).

Key Points: 
  • LAKEWOOD, Colo., June 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (4Q21) and full year ended March 31, 2021 (FY21).
  • Sterilization and Disinfection Control (41% of revenues in 4Q21) delivered strong results in the quarter with organic revenues growth of 11% versus prior year.
  • Driven primarily by the strengthening Euro and increases in volumes, quarter over quarter gross profit percentage increased 70 bps to 76%.
  • In the fourth quarter, organic growth of 11% brought full year organic growth to 1%.

Mesa Labs Reports Third Quarter Results for FY21

Retrieved on: 
Wednesday, February 3, 2021
Cloud infrastructure, mLab, NoSQL, mLab, Computing, Computer companies, California

LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (3Q21) and nine months ended December 31, 2020.

Key Points: 
  • LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (3Q21) and nine months ended December 31, 2020.
  • Excluding unusual items in both quarters, operating income would have decreased by 49% to $2,749 as compared to the same quarter in the prior year.
  • Total revenues for the quarter, excluding the Cold Chain Packaging division (which we exited during 3Q20), increased 9% while organic revenues increased 1% as compared to the prior year.
  • Instruments (26% of revenues in 3Q21) total and organic revenues contracted 10% compared to the same quarter last year.

BigID and MongoDB Deliver Scalable Data Intelligence for Enterprise Data in the Cloud

Retrieved on: 
Thursday, December 17, 2020
Data management, Computing, NoSQL, Distributed computing architecture, MongoDB, Structured storage, Cloud infrastructure, MongoDB Inc., mLab

With this partnership, BigID extends deep data insight for optimized MongoDB solutions: joint customers can automatically find, classify, and catalog their sensitive and personal data across their MongoDB applications - and across their data landscape.

Key Points: 
  • With this partnership, BigID extends deep data insight for optimized MongoDB solutions: joint customers can automatically find, classify, and catalog their sensitive and personal data across their MongoDB applications - and across their data landscape.
  • Targeted Action: The BigID Platform includes an application framework of privacy, security, and governance apps to take action on data in MongoDB for end-to-end data lifecycle management.
  • Customers can now leverage MongoDB Atlas and MongoDB Enterprise Advanced for simplified, secure and enterprise-grade management of their MongoDB instances that underpin the platform.
  • "Our strategic partnership with BigID will allow our customers to meet their enterprise data requirements and leverage MongoDB Atlas or MongoDB Enterprise Advanced.

Mesa Labs Reports Second Quarter Results for FY21

Retrieved on: 
Thursday, November 5, 2020
Computing, Cloud infrastructure, mLab, NoSQL, California, Computer companies, Electronic Arts

LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (2Q21) and six months ended September 30, 2020.

Key Points: 
  • LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (2Q21) and six months ended September 30, 2020.
  • Biopharmaceutical labs continued to reopen in the quarter releasing some pent-up demand that normally would have occurred in the previous quarter.
  • Volume growth and better discounting controls resulted in gross profit percentage expanding by 380 bps quarter over quarter.
  • The second quarter continued to demonstrate our dedication to our essential customers and to the safety and well-being of the Mesa team.

MongoDB Atlas is the First Cloud Database to Enable Customers to Run Applications Simultaneously on all Major Cloud Providers

Retrieved on: 
Tuesday, October 20, 2020
Computing, Cloud computing, Cloud infrastructure, IT infrastructure, MongoDB, Microsoft Azure, Amazon Web Services, Cloud database, mLab, MongoDB Inc.

For the first time, customers can deploy a fully managed, distributed database across Amazon Web Services (AWS), Google Cloud, and Microsoft Azure simultaneously.

Key Points: 
  • For the first time, customers can deploy a fully managed, distributed database across Amazon Web Services (AWS), Google Cloud, and Microsoft Azure simultaneously.
  • This means customers can take advantage of the benefits of deploying applications across multiple cloud providers without the added operational complexity of managing data replication and migration across clouds.
  • MongoDB Atlas multi-cloud clusters enables organizations to extend the geographic reach of their applications by allowing them to replicate data across all three major cloud providers to any of the currently 79 supported cloud regions worldwide.
  • No one else offers this today, making MongoDB Atlas the most advanced cloud database available in the market."

Mesa Labs Reports First Quarter Results

Retrieved on: 
Thursday, August 6, 2020
Hygiene, Cloud infrastructure, mLab, NoSQL, Sterilization, Disinfectant, Computing, Branches of biology, Articles

LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (1Q21).

Key Points: 
  • LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (1Q21).
  • Total revenues, excluding the Cold Chain Packaging division (which we exited during 3Q20) increased 20% for 1Q21, while organic revenues declined 4% quarter over quarter.
  • Sterilization and Disinfection Control (44% of revenues in 1Q21) delivered strong results in the quarter with total and organic revenues growth of 8%.
  • Division gross profit percentage contracted 270 bps quarter over quarter primarily due to lower sales volumes.

MESA LABS DECLARES QUARTERLY DIVIDEND

Retrieved on: 
Monday, July 6, 2020
Hygiene, Mesa Air Group, Dividend, Shareholders, Sterilization, mLab, Manufacturing Enterprise Solutions Association, Mesa Airlines, Airlines

Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa Labs or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

Key Points: 
  • Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa Labs or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.
  • The dividend will be payable on September 15, 2020, to shareholders of record at the close of business on August 31, 2020.
  • Mesa Labs is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries.
  • Mesa Labs offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Retrieved on: 
Tuesday, June 16, 2020
Initial public offering, Financial markets, Software, Free software, Computing, Mesa Air Group, Corporate finance, Mesa Airlines, mLab, Mesa, Shelf registration, Prospectus

Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (Mesa Labs) today announced that the underwriters for its previously announced public offering of common stock have fully exercised their option to purchase 90,000 additional shares of Mesa Labs common stock.

Key Points: 
  • Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (Mesa Labs) today announced that the underwriters for its previously announced public offering of common stock have fully exercised their option to purchase 90,000 additional shares of Mesa Labs common stock.
  • The initial closing of the offering occurred on June12, 2020, and the closing of the issuance of the additional shares occurred on June16, 2020.
  • Mesa Labs intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions.
  • The offering was effected pursuant to Mesa Labs shelf registration statement (including a base prospectus), which Mesa Labs filed with the Securities and Exchange Commission (the SEC).

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Retrieved on: 
Wednesday, June 10, 2020
Initial public offering, Financial economics, Finance, Corporate finance, Money, Stock market, Prospectus, Public offering, Stock, mLab

Lakewood, Colo., June 09, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (Mesa Labs) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a public offering price of $225.00 per share for gross proceeds of approximately $135million before deducting underwriting discounts and commissions and other estimated offering expenses.

Key Points: 
  • Lakewood, Colo., June 09, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (Mesa Labs) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a public offering price of $225.00 per share for gross proceeds of approximately $135million before deducting underwriting discounts and commissions and other estimated offering expenses.
  • In addition, Mesa Labs has granted the underwriters a 30-day option to purchase up to 90,000 additional shares.
  • Mesa Labs intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions.
  • Before investing in Mesa Labs common stock, investors should read the prospectus, including the documents incorporated by reference therein, and any free writing prospectus related to the offering.

Yugabyte Raises $30 Million In Series B Funding To Meet Growing Demand For Its Cloud Native, Geo-Distributed SQL Database

Retrieved on: 
Tuesday, June 9, 2020
Finance, Data management, Professional services, Technology, Software, Digital technology, Computing, Cloud infrastructure, NetApp, Kubernetes, Cloud computing, Google Cloud, Oracle Cloud, mLab

Yugabyte , the leader in open source distributed SQL databases, today announced that it has raised $30 million in an oversubscribed Series B round.

Key Points: 
  • Yugabyte , the leader in open source distributed SQL databases, today announced that it has raised $30 million in an oversubscribed Series B round.
  • Yugabytes commercial products include Yugabyte Platform , a self-managed private database-as-a-service offering available on any public, private, or hybrid cloud or Kubernetes infrastructure and Yugabyte Cloud , a fully-managed database service currently available on AWS and Google Cloud.
  • We built YugabyteDB from the ground up to meet the untapped cloud native database demand from small and large enterprises alike.
  • This round of funding from 8VC, Wipro Ventures, and others validates our approach, said Kannan Muthukkaruppan, co-founder and President, Yugabyte.